Is symptom-oriented follow-up still up to date?

Breast Care

Volumn 8, Issue 5, 2013, Pages 336-340

  Mundhenke, Christoph ^a   Moebus, Volker ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b SANOFI   (France)

Author keywords

Breast cancer follow up; Breast cancer subtypes; Imaging; Laboratory check up; Lead time

Indexed keywords

BREAST CANCER; BREAST METASTASIS; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SCREENING; CONSULTATION; CONTRALATERAL BREAST CANCER; DIAGNOSTIC IMAGING; DISEASE FREE SURVIVAL; FOLLOW UP; HORMONAL THERAPY; HUMAN; LIFESTYLE; MEDICAL HISTORY; MOLECULARLY TARGETED THERAPY; OVERALL SURVIVAL; PATIENT COUNSELING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SOCIAL PSYCHOLOGY; SYMPTOM; CANCER PALLIATIVE THERAPY; LONG TERM CARE; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PRACTICE GUIDELINE; SECOND CANCER; SYMPTOM ORIENTED FOLLOW UP; WEIGHT REDUCTION;

EID: 84890072754     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000356044     Document Type: Review

References (48)

1. The GIVIO Investigators: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA 1994;271:1587-1592.
2. Rosselli del Turco M, Palli D, Cariddi A, et al.: Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer Follow-Up. JAMA 1994;271:1593-1597.
3. Palli D, Russo A, Saieva C, et al.: Intensive vs clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-Up. JAMA 1999;281:1586.
4. Rojas MP, Telaro E, Moschetti I, et al.: Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev 2005;25: CD001768.
5. Fors EA, Bertheussen GF, Thune I, et al.: Psychosocial interventions as part of breast cancer rehabilitation programs? Results from a systematic review. Psychooncology 2011;20:909-918.
6. Hershman DL, Shao T, Kushi LH, et al.: Early discontinuation and non-Adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 2011;126:529-537.
7. Drew PJ, Kerin MJ, Turnbull LW, et al.: Routine screening for local recurrence following breastconserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast. Ann Surg Oncol 1998;5:265-270.
8. Grunfeld E, Dhesy-Thind S, Levine M: Clinical practice guidelines for the care and treatment of breast cancer: Follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 2005;172:1319-1320.
9. Harris L, Fritsche H, Mennel R, et al.: American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007;25:5287-5312.
10. Pan L, Han Y, Sun X, et al.: FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: A meta-Analysis. J Cancer Res Clin Oncol 2010;136:1007-1022.
11. Janni W, Rack B, Schindlbeck C, et al.: The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence. Cancer 2005;103:884-891.
12. Yerushalmi R, Kennecke H, Woods R, et al.: Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence. Breast Cancer Res Treat 2009;117:365-370.
13. Hooning MJ, Aleman BM, Hauptmann M, et al.: Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. J Clin Oncol 2008;26:5561-5568.
14. Bertelsen L, Mellemkjaer L, Christensen J, et al.: Age-specific incidence of breast cancer in breast cancer survivors and their first-degree relatives. Epidemiology 2009;20:175-180.
15. Montgomery DA, Krupa K, Cooke TG: Follow-up in breast cancer: Does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer 2007;97:1632-1641.
16. Beinart G, Gonzalez-Angulo AM, Broglio K, et al.: Clinical course of 771 patients with bilateral breast cancer: Characteristics associated with overall and recurrence-free survival. Clin Breast Cancer 2007; 7:867-874.
17. Samant RS, Olivotto IA, Jackson JS, et al.: Diagnosis of metachronous contralateral breast cancer. Breast J 2001;7:405-410.
18. Kollias J, Ellis IO, Elston CW, et al.: Prognostic significance of synchronous and metachronous bilateral breast cancer. World J Surg 2001;25:1117-1124.
19. Andersson M, Jensen MB, Engholm G, et al.: Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001. Acta Oncol 2008;47: 755-764.
20. Schaapveld M, Visser O, Louwman MJ, et al.: Risk of new primary nonbreast cancers after breast cancer treatment: A Dutch population-based study. J Clin Oncol 2008;26:1239-1246.
21. Chan JK, Manuel MR, Cheung MK, et al.: Breast cancer followed by corpus cancer: Is there a higher risk for aggressive histologic subtypes? Gynecol Oncol 2006;102:508-512.
22. Kirova YM, De Rycke Y, Gambotti L, et al.: Second malignancies after breast cancer: The impact of different treatment modalities. Br J Cancer 2008;98:870-874.
23. Brown LM, Chen BE, Pfeiffer RM, et al.: Risk of second non-hematological malignancies among 376,825 breast cancer survivors. Breast Cancer Res Treat 2007;106:439-451.
24. Nielsen I, Gordon S, Selby A: Breast cancer-related lymphedema risk reduction advice: A challenge for health professionals. Cancer Treat Rev 2008; 34:621-628.
25. Kaufmann M, Jatoi I, Petit JI (eds): Atlas der Brustchirurgie. Heidelberg, Springer, 2008.
26. Bonneterre J, Roche H, Kerbrat P, et al.: Longterm cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group. J Clin Oncol 2004;22:3070-3079.
27. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: Follow-up after treatment for breast cancer. CMAJ 1998;158(suppl 3):S65-S70.
28. Grunfeld E, Dhesy-Thind S, Levine M: Clinical practice guidelines for the care and treatment of breast cancer: Follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 2005;172:1319-1320.
29. Fan HG, Houede-Tchen N, Yi QL, et al.: Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- And 2-year follow-up of a prospective controlled study. J Clin Oncol 2005;23:8025-8032.
30. Hickey M, Saunders C, Partridge A, et al.: Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Ann Oncol 2008;19:1669-1680.
31. Schover LR: Premature ovarian failure and its consequences: Vasomotor symptoms, sexuality, and fertility. J Clin Oncol 2008;26:753-758.
32. Gerber B, Dieterich M, Muller H: Controversies in preservation of ovary function and fertility in patients with breast cancer. Breast Cancer Res Treat 2008;108:1-7.
33. Beasley JM, Kwan ML, Chen WY, et al.: Meeting the physical activity guidelines and survival after breast cancer: Findings from the After Breast Cancer Pooling Project. Breast Cancer Res Treat 2012;131:637-643.
34. Ewertz M, Jensen MB, Gunnarsdóttir KÁ, Højris I, Jakobsen EH, Nielsen D, Stenbygaard LE, Tange UB, Cold S: Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 2011; 29:25-31.
35. Voskuil DW, van Nes JG, Junggeburt JM, et al.: Maintenance of physical activity and body weight in relation to subsequent quality of life in postmenopausal breast cancer patients. Ann Oncol 2010;21:2094-2101.
36. National Comprehensive Cancer Network: NCCNGuidelines version 1, 2011. Cancer-related fatigue. www.nccn.org.
37. Bicego D, Brown K: Effects of exercise on quality of life in women living with breast cancer: A systematic review. Breast J 2009;15:45-51.
38. Cramp F, Daniel J: Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2008;2:CD006145.
39. Griffiths RI, Danese MD, Gleeson ML, Valderas JM: Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: An observational cohort study based on SEER-Medicare. BMC Cancer 2012;12:613.
40. Chlebowski RT, Blackburn GL, Thomson CA, et al.: Dietary fat reduction and breast cancer outcome: Interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 2006;98:1767-1776.
41. Demark-Wahnefried W, Case LD, Blackwell K, et al.: Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy. Clin Breast Cancer 2008;8:70-79.
42. McNeely ML, Campbell KL, Rowe BH, et al.: Effects of exercise on breast cancer patients and survivors: A systematic review and meta-Analysis. CMAJ 2006;175:34-41.
43. Calle EE, Rodriguez C, Walker-Thurmond K, et al.: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638.
44. Ewertz M, Jensen MB, Gunnarsdóttir KA, et al.: Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 2011;29:25-31.
45. Voskuil DW, van Nes JG, Junggeburt JM, et al.: Maintenance of physical activity and body weight in relation to subsequent quality of life in postmenopausal breast cancer patients. Ann Oncol 2010; 21:2094-2101.
46. Braithwaite D, Izano M, Moore DH, et al.: Smoking and survival after breast cancer diagnosis: A prospective observational study and systematic review. Breast Cancer Res Treat 2012;136:521-533.
47. Khatcheressian JL, Smith TJ: Randomized trial of long-Term follow-up for early-stage breast cancer: A comparison of family physician versus specialist care. J Clin Oncol 2006;24:835-837.
48. National Comprehensive Cancer Network: NCCN Guidelines version 2, 2011. Breast cancer. Clinical Practice Guidelines in OncologyTM. www.nccn.org.